HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Electrophysiological assessment of Guillain-Barré syndrome with both Gal-C and ganglioside antibodies; tendency for demyelinating type.

Abstract
Whether patients who have GBS with antibodies to galactocerebroside (Gal-C) and gangliosides (Gal-C-GS-GBS) more often have demyelinating or axonal neuropathy remains controversial. We assessed the electrophysiological data from 16 patients with Gal-C-GS-GBS based on the two established criteria to clarify this issue. In this largest cohort of Gal-C-GS-GBS, eight patients had demyelinating neuropathy and none exhibited axonal neuropathy on either criterion. These data indicated that antibodies to Gal-C, a myelin antigen, might predominantly be associated with demyelinating neuropathy, even in the presence of concomitant antibodies to gangliosides.
AuthorsMakoto Samukawa, Motoi Kuwahara, Miyuki Morikawa, Rino Ueno, Yukihiro Hamada, Kazuo Takada, Makito Hirano, Yoshiyuki Mitsui, Masahiro Sonoo, Susumu Kusunoki
JournalJournal of neuroimmunology (J Neuroimmunol) Vol. 301 Pg. 61-64 (12 15 2016) ISSN: 1872-8421 [Electronic] Netherlands
PMID27823807 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2016 Elsevier B.V. All rights reserved.
Chemical References
  • Autoantibodies
  • Cytokines
  • Galactosylceramides
  • Gangliosides
  • galactocerebroside
Topics
  • Action Potentials (physiology)
  • Adult
  • Aged
  • Aged, 80 and over
  • Autoantibodies (blood)
  • Child
  • Cytokines (blood)
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Galactosylceramides (immunology)
  • Gangliosides (immunology)
  • Guillain-Barre Syndrome (blood, diagnosis, physiopathology)
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Mycoplasma pneumoniae (immunology)
  • Neural Conduction (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: